Sanofi swaps top ex­ecs with Bay­er, trig­ger­ing a re­or­ga­ni­za­tion that puts Chi­na in the head­lights

Sanofi and Bay­er are swap­ping out two top ex­ecs, trig­ger­ing a re­or­ga­ni­za­tion at the French phar­ma com­pa­ny that will al­low for a clos­er fo­cus on Chi­na.

Ste­fan Oel­rich is leav­ing his job at Sanofi as head of the di­a­betes and car­dio op­er­a­tion, head­ed back to Bay­er as the new chief of its phar­ma group, where he be­gan his ca­reer. Sanofi, mean­while, re­cruit­ed Bay­er’s Di­eter Weinand — who Oel­rich is re­plac­ing — and as­signed him to the of­fice in Bridge­wa­ter, NJ, where he’ll run a new pri­ma­ry care unit that com­bines di­a­betes/car­dio and their “Es­tab­lished Prod­ucts” group. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER